273 related articles for article (PubMed ID: 29452192)
1. Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse.
Park SE; Song KI; Kim H; Chung S; Youn I
Behav Brain Res; 2018 May; 344():42-47. PubMed ID: 29452192
[TBL] [Abstract][Full Text] [Related]
2. A time-course study of behavioral and electrophysiological characteristics in a mouse model of different stages of Parkinson's disease using 6-hydroxydopamine.
Park SE; Song KI; Suh JK; Hwang D; Youn I
Behav Brain Res; 2015 May; 284():153-7. PubMed ID: 25698596
[TBL] [Abstract][Full Text] [Related]
3. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
Truong L; Allbutt H; Kassiou M; Henderson JM
Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
[TBL] [Abstract][Full Text] [Related]
4. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
Bagga V; Dunnett SB; Fricker RA
Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
[TBL] [Abstract][Full Text] [Related]
5. Neuronal activity in the medial associative-limbic and lateral motor part of the rat subthalamic nucleus and the effect of 6-hydroxydopamine-induced lesions of the dorsolateral striatum.
Lindemann C; Alam M; Krauss JK; Schwabe K
J Comp Neurol; 2013 Oct; 521(14):3226-40. PubMed ID: 23787707
[TBL] [Abstract][Full Text] [Related]
6. A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion.
Boix J; Padel T; Paul G
Behav Brain Res; 2015 May; 284():196-206. PubMed ID: 25698603
[TBL] [Abstract][Full Text] [Related]
7. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
[TBL] [Abstract][Full Text] [Related]
8. Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.
Rizelio V; Szawka RE; Xavier LL; Achaval M; Rigon P; Saur L; Matheussi F; Delattre AM; Anselmo-Franci JA; Meneses M; Ferraz AC
Braz J Med Biol Res; 2010 Jan; 43(1):85-95. PubMed ID: 19967265
[TBL] [Abstract][Full Text] [Related]
9. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the neuronal firing patterns in the subthalamic nucleus with graded dopaminergic cell loss in the nigrostriatal pathway.
Park SE; Song KI; Suh JK; Youn I
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2510-3. PubMed ID: 26736802
[TBL] [Abstract][Full Text] [Related]
11. Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
Wang Y; Chen X; Wang T; Sun YN; Han LN; Li LB; Zhang L; Wu ZH; Huang C; Liu J
Life Sci; 2014 Dec; 119(1-2):18-27. PubMed ID: 25445222
[TBL] [Abstract][Full Text] [Related]
12. Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.
Chen L; Liu Z; Tian Z; Wang Y; Li S
Stereotact Funct Neurosurg; 2000; 75(2-3):66-75. PubMed ID: 11740172
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway.
Galati S; Stanzione P; D'Angelo V; Fedele E; Marzetti F; Sancesario G; Procopio T; Stefani A
J Physiol; 2009 Sep; 587(Pt 18):4405-23. PubMed ID: 19622605
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model.
Wang Y; Wang Y; Liu J; Wang X
Neurosci Bull; 2018 Jun; 34(3):476-484. PubMed ID: 29508251
[TBL] [Abstract][Full Text] [Related]
16. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
[TBL] [Abstract][Full Text] [Related]
17. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
Howells FM; Russell VA; Mabandla MV; Kellaway LA
Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
[TBL] [Abstract][Full Text] [Related]
18. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
[TBL] [Abstract][Full Text] [Related]
19. 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.
Kupsch A; Schmidt W; Gizatullina Z; Debska-Vielhaber G; Voges J; Striggow F; Panther P; Schwegler H; Heinze HJ; Vielhaber S; Gellerich FN
J Neural Transm (Vienna); 2014 Oct; 121(10):1245-57. PubMed ID: 24627045
[TBL] [Abstract][Full Text] [Related]
20. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
